2 June 2016 EpigenomicsNet features Oryzon CSO Tamara Maes on Epigenetic drug development Share: X Facebook Linkedin CSO Tamara Maes is interviewed on the development of the epigenetic drug ORY-2001 for treatment of neurodegenerative diseases.
